| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zynerba Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 0 | $1.33 | 10 Oct 2023 | Direct | |
| Zynerba Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 10 Oct 2023 | Direct |